Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4156 AL 4170

Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis

Chen R, Chan PT, Chu H, Lin YC, Chang PC, Chen CY, Chou KR.

PLoS One. 2017 Aug 21;12(8):e0183586. doi: 10.1371/journal.pone.0183586. eCollection 2017.

Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer's Disease

Kou X, Chen N.

Nutrients. 2017 Aug 24;9(9):927. doi: 10.3390/nu9090927.

Personalized Medicine and Resurrected Hopes for the Management of Alzheimer's Disease: A Modular Approach Based on GSK-3β Inhibitors

Arafa RK, Elghazawy NH.

Adv Exp Med Biol. 2017;1007:199-224. doi: 10.1007/978-3-319-60733-7_11.

Targeting NAD(+) degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty

Ruan Q, Ruan J, Zhang W, Qian F, Yu Z.

Pharmacol Res. 2018 Feb;128:345-358. doi: 10.1016/j.phrs.2017.08.010. Epub 2017 Aug 25.

AChE Inhibitors and NMDA Receptor Antagonists in Advanced Alzheimer's Disease

Glynn-Servedio BE, Ranola TS.

Consult Pharm. 2017 Sep 1;32(9):511-518. doi: 10.4140/TCP.n.2017.511.

DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study

Karimi M, Vedin I, Freund Levi Y, Basun H, Faxén Irving G, Eriksdotter M, Wahlund LO, Schultzberg M, Hjorth E, Cederholm T, Palmblad J.

Am J Clin Nutr. 2017 Oct;106(4):1157-1165. doi: 10.3945/ajcn.117.155648. Epub 2017 Aug 30.

Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels

Youn K, Yu Y, Lee J, Jeong WS, Ho CT, Jun M.

Nutrients. 2017 Sep 4;9(9):973. doi: 10.3390/nu9090973.

Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer's Disease

Voytyuk I, De Strooper B, Chávez-Gutiérrez L.

Biol Psychiatry. 2018 Feb 15;83(4):320-327. doi: 10.1016/j.biopsych.2017.08.001. Epub 2017 Aug 10.

Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis

Kishi T, Matsunaga S, Oya K, Nomura I, Ikuta T, Iwata N.

J Alzheimers Dis. 2017;60(2):401-425. doi: 10.3233/JAD-170424.

[Treatment of dementia]

Blom K, van den Elsen GAH, Koek HL, Sanders JB, Kruithof HC, Claassen JAHR.

Ned Tijdschr Geneeskd. 2017;161:D1851.

Synthesis, Molecular Modeling, and Evaluation of Novel Sulfonylhydrazones as Acetylcholinesterase Inhibitors for Alzheimer's Disease

Fernandes TB, Cunha MR, Sakata RP, Candido TM, Baby AR, Tavares MT, Barbosa EG, Almeida WP, Parise-Filho R.

Arch Pharm (Weinheim). 2017 Nov;350(11). doi: 10.1002/ardp.201700163. Epub 2017 Sep 22.

The role of the immune system in Alzheimer disease: Etiology and treatment

Jevtic S, Sengar AS, Salter MW, McLaurin J.

Ageing Res Rev. 2017 Nov;40:84-94. doi: 10.1016/j.arr.2017.08.005. Epub 2017 Sep 21.

Therapeutic peptides for CNS indications: Progress and challenges

Morimoto BH.

Bioorg Med Chem. 2018 Jun 1;26(10):2859-2862. doi: 10.1016/j.bmc.2017.09.011. Epub 2017 Sep 9.

Endosomal Traffic Jams Represent a Pathogenic Hub and Therapeutic Target in Alzheimer's Disease

Small SA, Simoes-Spassov S, Mayeux R, Petsko GA.

Trends Neurosci. 2017 Oct;40(10):592-602. doi: 10.1016/j.tins.2017.08.003.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias